Gå direkt till innehåll

Ämnen: Medicinsk forskning

  • Pressrelease: Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone
    Pressrelease: Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone
    Licens:
    All rights reserved
    Filformat:
    .pdf
  • Haleon Mocked Up advertising.png
    Haleon Mocked Up advertising.png
    Licens:
    All rights reserved
    Filformat:
    .png
    Storlek:
    1038 x 617, 584 KB
  • Pressmeddelande - Första långverkande hivbehandlingen nu tillgänglig Sverige
    Pressmeddelande - Första långverkande hivbehandlingen nu tillgänglig Sverige
    Licens:
    All rights reserved
    Filformat:
    .pdf
  • ViiV Healthcare presents positive long-term data , long-acting, injectable treatment regimen in adults living with HIV-1
    ViiV Healthcare presents positive long-term data , long-acting, injectable treatment regimen in adults living with HIV-1
    Licens:
    All rights reserved
    Filformat:
    .pdf
  • GSK filing accepted by European Medicines Agency for Trelegy Ellipta use in adult patients with asthma
    GSK filing accepted by European Medicines Agency for Trelegy Ellipta use in adult patients with asthma
    Licens:
    All rights reserved
    Filformat:
    .pdf